New figures released by the Office of the Public Guardian (OPG) revealed there were 1,729 investigations into misuse last year. Davina Hehir, Director of Policy at Compassion in Dying, a national charity that helps people prepare for the end of life, said: “An LPA for Health and Welfare is an important tool to enable someone’s
Lasting Power of Attorney refund scheme announced
We were saddened to read the story of Mrs Lillian Treacher, who had been living with cancer for several years when she was admitted to hospital in April 2014 and sadly died there a week later.
We were shocked to read a letter printed in The Daily Telegraph on the 11th of January 2018, in which Louise Broughton details the experience of her mother who is currently in a nursing home with vascular dementia.
Compassion in Dying has responded to today’s news that the family of Mrs Brenda Grant of Nuneaton, Warwickshire has received a £45,000 payout from The George Eliot Hospital after she received life-prolonging treatment against her will for 22 months.
We can help you ask the right questions, get the information you need, and make the decisions that are right for you.
Innovative new publication uses voices of dying people to empower others to make informed end-of-life decisions.
Natalie Koussa, Director of Partnerships & Services at Compassion in Dying, said, “This is another tragic example of what can happen when people do not record their wishes for future medical treatment and care. Our thoughts go out to Mr Y’s loved ones, who have already suffered the heartbreak of seeing him sustain severe brain
In response to the case of Mrs P, case currently being heard at the Court of Protection in which there is a dispute over whether clinically-assisted nutrition and hydration (CANH) should be withdrawn from a brain-damaged woman in a minimally-conscious state: Usha Grieve, Director of Information & Partnerships at Compassion in Dying, said, “This case
The national controlled drugs summit focuses on the safe use, prescribing and management of controlled drugs including monitoring adherence against the NICE guidance on the safe use and management of controlled drugs.
